DARE insider buying & filings

DAREDare Bioscience, Inc.

NasdaqCM · Healthcare · $14.36M

$0.7300

4 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jul 2 · scanned 7m ago

No price data yet — the yfinance scanner hasn't produced bars for DARE.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$14.36M

Float

12.9M

66% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

10.5

Institutional stakes

▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing

2 filingsnewest first

13GLind Global Fund III LP5.7%Aug 28

13GL1 Capital Global Opportunities Master Fund, Ltd.10.0%Aug 24

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jul 2GRANTGrossman Jessica D.Directordirect26,066 sh—

Jul 2GRANTKelley Susan L.Directordirect23,696 sh—

Jul 2GRANTMatz Gregory WDirectordirect30,805 sh—

Jul 2GRANTRastetter William HDirectordirect38,862 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice